Skip to content
Sign In

Main Navigation

James Sharp Logo
  • Individuals
    Individuals

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service
  • Charities & Trustees
    Charities & Trustees

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

  • Companies
    Companies

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

  • News & Insights
    • News & Insights
    • Current Research Coverage List
  • About Us
    • About Us
    • Our People
  • Conectus Portal
  • Contact Us

News & Insights

Stock News Highlights

19th July 2024

19th July 2024

UK markets declined this week with the FTSE 100 Index falling by 1.3% to trade at 8,165 points at the time of writing. The…

12th July 2024

12th July 2024

UK markets were little changed this week, with the FTSE 100 Index falling 0.12% to trade at 8,255 points at the time of writing….

5th July 2024

5th July 2024

UK markets and Sterling rose this week after the Labour Party secured a resounding and long-predicted General Election victory, with the FTSE 100 Index…

28th June 2024

28th June 2024

UK markets declined this week as investors remained cautious ahead of the UK’s July 4th General Election, with the FTSE 100 Index falling by…

More Stock News Highlights

Market News

GSK plc- Exdensur Approved in the UK for Asthma Treatment

16 December 2025

AstraZeneca Announces Subcutaneous Saphnelo Gets EU Approval

16 December 2025

AstraZeneca Announce FDA Approval for Enhertu

16 December 2025

B.P. Marsh & Partners plc Announce Special Dividend

15 December 2025

Hargreaves Services plc Trading Update and Notice of Interim Results

11 December 2025

DotDigital Group plc Commencement of Share Buy-Back Prgramme

10 December 2025

GSK’227 US FDA Orphan Drug Designation in SCLC

10 December 2025

More Market News

Insights

Blog

Stock Listings

Current Research Coverage List

Current Research Coverage List

James Sharp undertakes independent research on a selection of securities and funds. Our list as shown here is updated on a quarterly basis. Risk...

Home > News & Insights

James Sharp white Logo
Sign In
Linkedin Icon

The Exchange
5 Bank Street
Bury, Lancashire
BL9 0DN

Tel: 0161 764 4043

Fax: 0161 764 1628

Email: mail@jamessharp.co.uk

Linkedin Icon

James Sharp & Co is a trading name
of James Sharp & Co LLP (0C422665)

Members of the LLP are referred to as Partners

  • Downloads & Resources
  • Complaints
  • Financial Compensation Scheme
  • Conectus Portal

  • Cyber Essentials Certification
  • Website Terms & Conditions
  • Privacy Policy
  • Cookie policy
  • Consent Preferences

Email Newsletter Sign-up

Consent(Required)
What we do with you information. Find out more

© Copyright 2010-2026. All rights reserved. James Sharp & Co. Authorised & Regulated by the Financial Conduct Authority
Member of the London Stock Exchange - Member of the Aquis Stock Exchange - Member of PIMFA

Website by ICG